Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Amphastar Pharma
(NQ:
AMPH
)
43.48
+0.74 (+1.73%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
328,465
Open
42.62
Bid (Size)
42.70 (1)
Ask (Size)
44.63 (1)
Prev. Close
42.74
Today's Range
42.19 - 43.60
52wk Range
38.43 - 67.66
Shares Outstanding
48,901,965
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade
May 16, 2024
The FTC is putting these three drug stocks at risk by trying to strip their therapies of protection from generics.
Via
InvestorPlace
Topics
Intellectual Property
Exposures
Intellectual Property
Exploring NASDAQ:AMPH's growth characteristics.
May 15, 2024
AMPHASTAR PHARMACEUTICALS IN (NASDAQ:AMPH) showing high EPS and FCF growth while beating expectations
Via
Chartmill
Performance
YTD
-30.20%
-30.20%
1 Month
+8.56%
+8.56%
3 Month
-19.57%
-19.57%
6 Month
-22.15%
-22.15%
1 Year
-16.86%
-16.86%
More News
Read More
Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care Conference
May 09, 2024
Via
ACCESSWIRE
AMPH Stock Earnings: Amphastar Pharma Beats EPS, Misses Revenue for Q1 2024
May 08, 2024
Via
InvestorPlace
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024
May 08, 2024
Via
ACCESSWIRE
Federal Trade Commission Targets 'Junk Patent Listings' For Diabetes, Weight Loss, Asthma Drugs From Companies Like Novo Nordisk, AstraZeneca
May 01, 2024
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
NASDAQ:AMPH, an undervalued stock with good fundamentals.
March 12, 2024
Via
Chartmill
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023
February 28, 2024
Via
ACCESSWIRE
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024
April 30, 2024
Via
ACCESSWIRE
Amphastar Pharmaceuticals Interested In Potential Acquisitions In Endocrinology-Focused Companies
April 10, 2024
Via
Benzinga
Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
April 01, 2024
Via
ACCESSWIRE
Amphastar Pharmaceuticals to Present at the Barclays 26th Annual Global Healthcare Conference
March 06, 2024
Via
ACCESSWIRE
Delving into NASDAQ:AMPH's Growth Prospects.
February 28, 2024
Via
Chartmill
Earnings Outlook For Amphastar Pharma
February 27, 2024
Via
Benzinga
Is NASDAQ:AMPH a Fit for Growth Investing Strategies?
February 14, 2024
Via
Chartmill
Is NASDAQ:AMPH a Fit for Growth Investing Strategies?
February 07, 2024
Via
Chartmill
Unlocking the Growth Potential of NASDAQ:AMPH.
January 23, 2024
Via
Chartmill
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2024
February 20, 2024
Via
ACCESSWIRE
CRISPR Therapeutics Stock Shows Rising Relative Strength, Hits 90+
February 13, 2024
Via
Investor's Business Daily
3 Once-in-a-Lifetime Biotech Stocks With Unprecedented Surge Potential
February 05, 2024
Via
InvestorPlace
Axsome Therapeutics Stock Showing Leadership, Earns 91 RS Rating
January 23, 2024
Via
Investor's Business Daily
Despite its impressive fundamentals, NASDAQ:AMPH remains undervalued.
January 23, 2024
Via
Chartmill
What Vitamins Did For Healthy Living, Stemtech Corporation (OTCQB: STEK) Says It Is Doing For Anti-Aging With Stem Cell Nutrition
January 19, 2024
Via
Benzinga
NASDAQ:AMPH is not too expensive for the growth it is showing.
January 17, 2024
Via
Chartmill
Jim Cramer Says Hold Onto This Biotech Stock: 'I Don't Understand Why It's So Inexpensive'
January 17, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.